(Q37911259)

25 August 2017

title

Dietary methyl-consuming compounds and metabolic syndrome (English)

1 reference

25 August 2017

1 reference

Shi-Sheng Zhou

1

1 reference

25 August 2017

Yi-Ming Zhou

series ordinal

2

1 reference

25 August 2017

Da Li

series ordinal

3

1 reference

25 August 2017

Yong-Zhi Lun

series ordinal

4

1 reference

25 August 2017

language of work or name

1 reference

4 August 2011

1 reference

25 August 2017

published in

Hypertension Research

1 reference

25 August 2017

volume

34

1 reference

25 August 2017

issue

12

1 reference

25 August 2017

page(s)

1239-1245

1 reference

Oxidative stress and metabolic syndrome

25 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.133

Nutritional epigenomics of metabolic syndrome: new perspective against the epidemic

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.133

Prevalence and Trends in Obesity Among US Adults, 1999-2000

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.133

Metabolic syndrome, diabetes and atherosclerosis: influence of gene-environment interaction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.133

Age, homocysteine, and oxidative stress: relation to hypertension and type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.133

Plasma homocysteine levels are associated with ulceration of the foot in patients with type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.133

Epidemiology of homocysteine as a risk factor in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.133

Metabolic syndrome and homocysteine level as predictors of the severity of coronary artery disease in patients with carotid stenosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.133

Insulin promoter DNA methylation correlates negatively with insulin gene expression and positively with HbA(1c) levels in human pancreatic islets

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.133

Epigenetic regulation of insulin resistance in nonalcoholic fatty liver disease: impact of liver methylation of the peroxisome proliferator-activated receptor γ coactivator 1α promoter.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.133

Methylation of TFAM gene promoter in peripheral white blood cells is associated with insulin resistance in adolescents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.133

Betaine: a key modulator of one-carbon metabolism and homocysteine status

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.133

Effect of homocysteine-lowering treatment with folic Acid and B vitamins on risk of type 2 diabetes in women: a randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.133

Prevention: B vitamins and CVD--failure to find a simple solution

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.133

Meta-analysis of folic acid supplementation trials on risk of cardiovascular disease and risk interaction with baseline homocysteine levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.133

Homocysteine lowering with folic acid and B vitamins in vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.133

Biological and environmental determinants of plasma homocysteine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.133

Effect of drugs on homocysteine concentrations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.133

Co-administration of equimolar doses of betaine may alleviate the hepatotoxic risk associated with niacin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.133

Elevated plasma homocysteine levels in patients treated with levodopa: association with vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.133

Folate, Cobalamin, Cysteine, Homocysteine, and Arsenic Metabolism among Children in Bangladesh

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.133

Effect of dietary patterns on serum homocysteine: results of a randomized, controlled feeding study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.133

B-vitamin consumption and the prevalence of diabetes and obesity among the US adults: population based ecological study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.133

Chronic niacin overload may be involved in the increased prevalence of obesity in US children

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.133

The metabolic syndrome is not associated with homocysteinemia: the Persian Gulf Healthy Heart Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.133

Is plasma homocysteine level associated with metabolic syndrome components in adolescents?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.133

Effect of age on plasma homocysteine concentrations in young and elderly subjects considering serum vitamin concentrations and different lifestyle factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.133

Plasma homocysteine and malondialdehyde are correlated in an age- and gender-specific manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.133

Influence of arsenate and arsenite on signal transduction pathways: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.133

Biomarkers of oxidative stress and damage in human populations exposed to arsenic.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.133

Arsenic and diabetes and hypertension in human populations: a review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.133

Environmental cardiology: studying mechanistic links between pollution and heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.133

An Emerging Role for Epigenetic Dysregulation in Arsenic Toxicity and Carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.133

Safety of high-dose nicotinamide: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.133

Safety of niacin and simvastatin combination therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.133

Effects of niacin therapy that simulate neoplasia: hepatic steatosis with concurrent hepatic dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.133

Lipid profiles of plasma lipoproteins of fasted and fed normal and choline-deficient rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.133

The origin of chylomicron phosphatidylcholine in the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.133

Niacin status, NAD distribution and ADP-ribose metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.133

Nicotinamide overload may play a role in the development of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.133

Dietary intake and the development of the metabolic syndrome: the Atherosclerosis Risk in Communities study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.133

Dietary patterns, meat intake, and the risk of type 2 diabetes in women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.133

Catecholaminergic systems in stress: structural and molecular genetic approaches.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.133

Plasma catecholamines and essential hypertension. An analytical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.133

Role of oxidative stress in cardiovascular diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.133

Toxicology update: the cardiotoxicity of the oxidative stress metabolites of catecholamines (aminochromes).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.133

Neurotoxicity and metabolism of the catecholamine-derived 3,4-dihydroxyphenylacetaldehyde and 3,4-dihydroxyphenylglycolaldehyde: the role of aldehyde dehydrogenase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.133

Plasma noradrenaline and its deaminated metabolites in essential hypertension and pheochromocytoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.133

Increased norepinephrine spillover into the jugular veins in essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.133

Homocysteine-lowering vitamins do not lower plasma S-adenosylhomocysteine in older people with elevated homocysteine concentrations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.133

Liver diseases and metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.133

Stress, inflammation and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.133

Biotransformation of drugs in human skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.133

Sedentary behavior, physical activity, and concentrations of insulin among US adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.133

Hyperhomocysteinemia in winter elite athletes: a longitudinal study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.133

Influenza and the winter increase in mortality in the United States, 1959-1999.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.133

Abnormal insulin sensitivity persists up to three years in pediatric patients post-burn

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.133

Divergent associations of plasma choline and betaine with components of metabolic syndrome in middle age and elderly men and women

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.133

7 January 2021

Homocysteine and vascular disease

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.133

7 January 2021

Betaine in human nutrition

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.133

7 January 2021

Metabolic abnormalities in cobalamin (vitamin B12) and folate deficiency.

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.133

7 January 2021

Arsenic methylation, oxidative stress and cancer--is there a link?

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.133

7 January 2021

Effect of the rate of niacin administration on the plasma and urine pharmacokinetics of niacin and its metabolites

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.133

7 January 2021

Impaired beta-cell function in human aging: response to nicotinic acid-induced insulin resistance

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.133

7 January 2021

Nicotinamide's effects on glucose metabolism in subjects at risk for IDDM

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.133

7 January 2021

Increased beta-cell secretory capacity as mechanism for islet adaptation to nicotinic acid-induced insulin resistance

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.133

7 January 2021

Niacin in the metabolic syndrome: more risk than benefit?

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.133

7 January 2021

FATTY LIVERS PRODUCED IN ALBINO RATS BY EXCESS NIACIN IN HIGH FAT DIETS. II. EFFECT OF CHOLINE SUPPLEMENTS.

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.133

7 January 2021

Nicotinamide methylation and its relation to NAD synthesis in rat liver tissue culture. Biochemical basis for the physiological activities of 1-methylnicotinamide

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.133

7 January 2021

Fate of nicotinamide differs due to an intake of nicotinamide

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.133

7 January 2021

Metabolic Effects of Nicotinamide Administration in Rats

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.133

7 January 2021

Plasma norepinephrine and dihydroxyphenylglycol in essential hypertension

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.133

7 January 2021

Application of an HPLC assay for the determination of folate derivatives in some vegetables, fruits and berries consumed in Finland

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.133

7 January 2021

Folate status response to controlled folate intake in pregnant women

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.133

7 January 2021

Concentrations of choline-containing compounds and betaine in common foods

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.133

7 January 2021

The physiology, pharmacology, and biochemistry of the eccrine sweat gland

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.133

7 January 2021

Identifiers

DOI

10.1038/HR.2011.133

1 reference

release_sk2ij6l4lve4dd7vxment435me

25 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/sk2ij6l4lve4dd7vxment435me

24 November 2022

mapped directly with Wikidata item

1 reference